KUALA LUMPUR: CCM Duopharma Biotech Bhd
has bought a 5.8% stake in South Korea’s SCM Lifescience Co, Ltd, which specialises in stem cell therapeutics, for RM20.24mil.
CCM Duopharma, which develops generic drugs and branded healthcare products, said this marked its foray into regenerative medicine.
Already a subscriber? Log in
The Star Festive Promo: Get 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
